Viewing nowPregabalin 150 mg Capsule
Pregabalin 150mg
Hard capsule · Prescription medication
Genewon Science Co., Ltd.

MFDS item code 201109151 · Approved 2011.10.25
Treatment of neuropathic pain, treatment of fibromyalgia, adjunctive treatment of partial-onset seizures
This medication is used for the treatment of peripheral and central neuropathic pain in adults. It is also used as an adjunct in the case of partial seizures in epilepsy, whether or not there are secondary generalized symptoms. Additionally, it is applied to the treatment of fibromyalgia, helping patients relieve pain. Thus, it improves various symptoms of pain and seizures associated with neurological conditions.
Administer the total daily dose of pregabalin orally in 2 divided doses, regardless of food. This drug is eliminated primarily by the kidneys; therefore, the dosage should be adjusted in patients with impaired renal function. (See section ‘5. Patients with renal impairment’.) 1. Neuropathic pain 1) Peripheral neuropathic pain Adults: The initial dose of this drug may be 150 mg/day. Based on each patient’s response and tolerability, the dose may be increased to 300 mg/day after 3 to 7 days. If necessary, it may then be increased at 7-day intervals up to a maximum of 600 mg/day. 2) Central neuropathic pain Adults: The initial dose of this drug may be 150 mg/day. Based on each patient’s response and tolerability, the dose may be increased to 300 mg/day after 1 week. After an additional 1 week, it may be increased to the target daily dose of 600 mg. If the target daily dose is not tolerated, a dose reduction may be considered. (See section ‘4. Discontinuation of treatment’.) 2. Epilepsy Adults: The initial dose of this drug may be 150 mg/day. Based on each patient’s response and tolerability, the dose may be increased to 300 mg/day after 1 week. If necessary, it may then be increased at 7-day intervals up to a maximum of 600 mg/day. 3. Fibromyalgia The recommended dose of this drug for fibromyalgia is 300 mg-450 mg/day. The initial dose is 75 mg twice daily (150 mg/day); based on efficacy and tolerability, it may be increased to 150 mg twice daily (300 mg/day) within 1 week. For patients who do not experience sufficient benefit at a dose of 300 mg/day, the dose may be increased to 225 mg twice daily (450 mg/day) within 1 week. Clinical studies have also been conducted at a dose of 600 mg/day, but there is no evidence of additional benefit or adequate tolerability at this dose. In view of dose-dependent adverse reactions, doses exceeding 450 mg/day are not recommended. 4. Discontinuation of treatment Based on current clinical experience, if treatment with this drug is discontinued, it should be withdrawn gradually over at least 1 week. 5. Patients with renal impairment Dose reduction in patients with impaired renal function should be individualized based on creatinine clearance. In patients undergoing hemodialysis, the daily dose of pregabalin should be adjusted based on renal function. In addition to the daily dose based on renal function, a supplemental dose should be administered promptly after each 4-hour hemodialysis session. [Table 1]. Pregabalin dosage based on renal function ≥60: Initial dose 150 (mg/day), maximum dose 600 (mg/day), BID or TID ≥30-<60: Initial dose 75 (mg/day), maximum dose 300 (mg/day), BID or TID ≥15-<30: Initial dose 25-50 (mg/day), maximum dose 150 (mg/day), QD or BID <15: Initial dose 25 (mg/day), maximum dose 75 (mg/day), QD Supplemental dose after hemodialysis: Initial dose 25, maximum dose 100, single dose b TID = total daily dose divided into 3 doses BID = total daily dose divided into 2 doses QD = once daily a: The total daily dose (mg/day) should be divided as specified under the method of administration. b: The supplemental dose refers to a dose administered once in addition to the regular dose. 6. Patients with hepatic impairment No dosage adjustment is necessary in patients with hepatic impairment. 8. Elderly patients (65 years of age and older) Dose reduction may be necessary in elderly patients with impaired renal function.
Children under 12 years of age: Administration is not recommended because data on safety and efficacy are insufficient. Adolescent patients aged 12-17 years: Administration is not recommended because data on safety and efficacy are insufficient.
This medication may increase the risk of suicidal thoughts or behavior, so mood changes and depressive symptoms should be closely monitored during treatment. This medication should not be used by individuals with allergies to its components, and patients with certain genetic lactase deficiencies should also avoid it. Diabetic patients should be cautious as weight gain after taking this medication may require adjustments to blood glucose control medications. If allergic reactions such as angioedema occur, the medication should be stopped immediately, and medical advice should be sought. Elderly patients should be particularly careful at the beginning of treatment as dizziness and drowsiness may increase the risk of falls. Transient visual disturbances or changes in vision may occur; if symptoms persist, consult a physician. Sudden discontinuation of the medication can lead to withdrawal symptoms such as insomnia, headaches, and anxiety, so the dose should be tapered gradually under medical supervision. Due to the risk of drug abuse, inform your healthcare provider about your mental health condition and history of drug use, and manage this closely. Patients with reduced kidney function may require dose adjustments. Patients with heart disease should be cautious of potential cardiovascular adverse reactions such as congestive heart failure while taking this medication. When used in combination with opioid analgesics, there may be an increased central nervous system depressant effect, so caution is advised when taken together. This medication poses a risk of respiratory depression, so adjustments may be necessary for those with respiratory or kidney diseases, as well as for elderly patients. In early pregnancy, there is a risk of congenital disabilities, so pregnant women should avoid taking this medication, and women of childbearing potential should use effective contraception. Breastfeeding women should consult with their healthcare provider about whether to stop breastfeeding or discontinue the medication, as it can be passed into breast milk. This medication may cause dizziness and drowsiness, so it is safest to avoid driving or operating dangerous machinery after taking it. Rarely, serious skin reactions may occur, so if symptoms like skin rashes or swelling occur, stop taking the medication immediately and inform your healthcare provider. In cases of overdose, symptoms such as mental confusion, drowsiness, and seizures may manifest; seek emergency treatment if suspected. This medication should be kept out of reach of children, and transferring it to another container should be avoided.
Suicidal ideation, suicidal behavior, depression, abnormal changes in mood and behavior, angioedema, facial swelling, perioral edema, upper respiratory tract edema, dizziness, drowsiness, loss of consciousness, confusion, mental disorder, blurred vision, changes in vision, insomnia, headache, nausea, anxiety, diarrhea, influenza-like illness, restlessness, depression, thoughts of suicide, pain, seizures, hyperhidrosis, misuse, abuse, dependence, weight gain, rhinitis, neutropenia, increased appetite, anorexia, hypoglycemia, confusion, disorientation, irritability, euphoria, decreased libido, depersonalization, dysesthesia, agitation, mood swings, emotional blunting, emotional elevation, difficulty finding appropriate terminology, hallucinations, abnormal dreams, increased libido, panic attacks, impulsivity, apathy, ataxia, motor coordination disorder, balance disturbance, amnesia, attention deficit, memory impairment, tremors, dysarthria, sensory disturbances, sensory loss, sedation, somnolence, cognitive impairment, nystagmus, language impairment, myoclonus, diminished reflexes, movement disorders, psychomotor agitation, position-related dizziness, hypersensitivity, burning sensation, activity tremor, syncope, confusion, hypokinesia, olfactory disturbances, taste loss, writing difficulty, diplopia, vertigo, auditory hypersensitivity, first-degree atrioventricular block, tachycardia, bradycardia, tachyarrhythmia, hypotension, hypertension, flushing, facial flushing, peripheral coldness, dyspnea, epistaxis, cough, nasal congestion, rhinitis, snoring, throat tension, nasal dryness, respiratory depression, vomiting, abdominal distension, constipation, dry mouth, bloating, hypersalivation, gastroesophageal reflux, oral sensory loss, ascites, dysphagia, pancreatitis, sweating, papular rash, urticaria, cold sweats, muscle cramps, arthralgia, back pain, limb pain, cervical spasms, joint swelling, myalgia, muscle spasm, neck pain, muscle rigidity, rhabdomyolysis, urinary disorders, urinary incontinence, reduced urination, renal failure, erectile dysfunction, delayed ejaculation, sexual dysfunction, dysmenorrhea, amenorrhea, mastalgia, nipple discharge, breast enlargement, peripheral edema, edema, gait abnormalities, falls, feelings of intoxication, sensory disturbances, fatigue, chest tightness, generalized edema, pain, fever, chills, weakness, thirst, weight gain, elevated alanine aminotransferase, increased serum creatine phosphokinase, elevated aspartate aminotransferase, elevated blood glucose, decreased platelet count, reduced serum potassium, increased serum creatinine, decreased white blood cell count, hypersensitivity, allergic reactions, headache, keratitis, congestive heart failure, pulmonary edema, tongue swelling, itching, Stevens-Johnson syndrome, toxic epidermal necrolysis, urinary retention, gynecomastia, apathy, delirium, paralysis (facial paralysis), affective disorder, drowsiness, confused state, agitation, restlessness, seizures, shock, anaphylaxis-like symptoms, mucocutaneous syndrome, erythema multiforme
Not everyone experiences these, and they can vary from person to person.
Store this medication in a tightly closed container to protect it from air and moisture, and keep it at room temperature between 15 to 30 degrees Celsius. Proper storage will help maintain the effectiveness of the medication for a long time.
A white hard capsule containing white powder
<For domestic use> 30 capsules/bottle, 60 capsules/bottle, <For export> 30 capsules (10 capsules/PTP x 3)
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowPregabalin 150mg
Hard capsule · Prescription medication
Genewon Science Co., Ltd.

Pregabalin 75mg
Hard capsule · Prescription medication
Viatris Korea Co., Ltd.

Pregabalin 150mg
Hard capsule · Prescription medication
Viatris Korea Co., Ltd.

Pregabalin 300mg
Hard capsule · Prescription medication
Viatris Korea Co., Ltd.

Pregabalin 150mg
Hard capsule · Prescription medication
Samjin Pharmaceutical Co., Ltd.

Pregabalin 75mg
Hard capsule · Prescription medication
Samjin Pharmaceutical Co., Ltd.

Pregabalin 75mg
Hard capsule · Prescription medication
Hanmi Pharm. Co., Ltd.

Pregabalin 150mg
Hard capsule · Prescription medication
Hanmi Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.